Navigation Links
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
Date:12/3/2008

peutic as a single agent for patients with Stage III or IV metastatic melanoma. Based on advice from clinical experts and detailed guidance received from the U.S. Food and Drug Administration (FDA) in an End-of-Phase 2 meeting, Vical successfully completed a Special Protocol Assessment (SPA) with the FDA for a Phase 3 trial (the Allovectin-7(R) Immunotherapeutic for Metastatic Melanoma, or AIMM trial) for certain patients with Stage III or Stage IV metastatic melanoma. The SPA agreement specifies that the trial design and planned analyses address the study's objectives and the resulting study data could provide the primary basis to support a product license application.

Allovectin-7(R) has been granted orphan drug designation for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan Products Development. Orphan drug designation provides U.S. marketing exclusivity for seven years if marketing approval is received from the FDA, in addition to certain tax benefits for qualifying expenses.

About the AIMM Trial

Vical is conducting a Phase 3 pivotal trial of the company's Allovectin-7(R) cancer immunotherapeutic as first-line therapy in chemotherapy-naive patients with Stage III or IV metastatic melanoma. The AIMM trial is being conducted in accordance with the SPA agreement at more than 60 clinical sites, and is currently enrolling patients in the United States, Canada and Europe. AnGes MG, Inc., is funding the clinical trial under a collaborative agreement with Vical.

The AIMM trial calls for enrollment of approximately 375 patients with Stage III or IV metastatic melanoma. Patients may have been previously treated with surgery, adjuvant therapy, and/or biotherapy, but cannot have been previously treated with cytotoxic chemotherapy. The patients will be randomized on a 2:1 basis: approximately 250 patients will be treated with Allovectin-7(R) and approximately 125
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
2. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
3. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
4. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
5. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
9. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
10. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 LifeScienceIndustryResearch.com announces ... Report on Global and China Lysine Industry to ... professional and the deep research report in this ... basic information including definition, classification specifications, application, industry ... Europe , Japan ...
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... "Medical Equipment Rental and Leasing - Global Strategic ... This report analyzes the worldwide markets for Medical Equipment ... separate comprehensive analytics for the US, Japan ... of World. Annual estimates and forecasts are ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vrd3bd/mammography ) ... - Global Strategic Business Report" report to their ... for Mammography Equipment in US$ Thousands by the following ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ...
Breaking Medicine Technology:Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2
(Date:4/18/2015)... New York, NY (PRWEB) April 18, 2015 ... their Internal Security Threat Report , which they say, “exposes ... on how many new malware variants were introduced in 2014 ... it took for Zero Day threats to be identified and ... – it is abundantly clear that doing business in a ...
(Date:4/18/2015)... French physician and gastronome Anthelme Brillat-Savarin understood ... uttered, “Tell me what you eat, and I will ... with stress or sadness has often been attributed to ... Data collected from their Emotional Eating Test ... but for different reasons. , Collecting data from 521 ...
(Date:4/17/2015)... 17, 2015 ERGO-Pedic Products, LLC, which ... two new products to help a broader range of ... relief are the second most common visitors to doctors. ... designed specifically to help relieve sitting pain. Then, only ... thousands of happy customers later, we began getting questions ...
(Date:4/17/2015)... “We have seen healing, a lot of healing, and ... Chaplain Shawn Kafader of Friendship Village. “People have found ... to contribute have created beautiful pieces of art.” For the ... program that was launched to benefit residents of the retirement ... the Art Institute in Chicago, worked as an intern at ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed Royce ... 1849 in congress on April 16, 2015 in an ... with the genetic disease. , The bill, similar ... first to create a federally led and financed initiative ... telangiectasia. This would effectively prevent premature death and disability ...
Breaking Medicine News(10 mins):Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Healing At Friendship Village Due To Art Therapy 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... Smoking before menopause, especially prior to giving birth, may ... of developing breast cancer, according to a report in ... Medicine, one of the JAMA/Archives journals. "Breast ... worldwide," according to background information in the article. "Tobacco ...
... MAYWOOD, Ill. -- The American Association of Clinical Endocrinologists ... and treatment of postmenopausal osteoporosis. Loyola physician Pauline Camacho, ... guidelines to manage this major public health issue. ... osteoporosis-related fractures and improve the quality of life for ...
... By Steven Reinberg HealthDay Reporter , MONDAY, ... disease and stroke in the United States is expected to ... new report says. According to the American Heart Association, ... costs for treating heart disease and stroke is largely due ...
... , MONDAY, Jan. 24 (HealthDay News) -- Many middle-aged ... lowering their blood pressure, researchers say. High systolic blood ... risk factor for cardiovascular disease and its common outcomes -- ... older women around the world, according to the report released ...
... problematic? Yes, according to a new study, which found ... and suggested that it may compromise informed consent. ... optimism in the research context are "always ethically benign, ... write the authors of the study, which appears in ...
... Jan. 24 (HealthDay News) -- Continual exposure to stress prompts ... control fear, vigilance and emotion, a new study suggests. ... among troops recently deployed to Afghanistan, and is reported in ... . "For the first time we can now conclude ...
Cached Medicine News:Health News:Smoking may be associated with increased risk of breast cancer 2Health News:Loyola physician helps develop national guidelines for osteoporosis 2Health News:U.S. Heart Disease Costs Expected to Soar 2Health News:U.S. Heart Disease Costs Expected to Soar 3Health News:Lowering BP Can Help Cut Women's Heart Disease Risk 2Health News:Unrealistic optimism appears common in early cancer trials 2Health News:Stress of War Spurs Changes in Brain Activity, Study Finds 2
Designated most popular model or size. 4 mm wide tip....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. Semi sharp. Curved 3 mm tips. Angled right and left....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
Medicine Products: